Revenue breakdown of Yiling Pharmaceutical by product 2022
In 2022, Yiling Pharmaceutical made more than half of its revenue from medications treating respiratory diseases. Meanwhile, cardiovascular and cerebrovascular products remained an important source of revenue. The company became highly profitable since the start of the COVID-19 pandemic when its traditional Chinese medicine product Lianhua Qingwen gained national popularity.